Does BEVACIZUMAB-BVZR Cause Neoplasm progression? 80 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 80 reports of Neoplasm progression have been filed in association with BEVACIZUMAB-BVZR. This represents 13.8% of all adverse event reports for BEVACIZUMAB-BVZR.
80
Reports of Neoplasm progression with BEVACIZUMAB-BVZR
13.8%
of all BEVACIZUMAB-BVZR reports
28
Deaths
13
Hospitalizations
How Dangerous Is Neoplasm progression From BEVACIZUMAB-BVZR?
Of the 80 reports, 28 (35.0%) resulted in death, 13 (16.3%) required hospitalization, and 1 (1.3%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB-BVZR. However, 80 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB-BVZR Cause?
Off label use (159)
Death (149)
Fatigue (57)
Hypertension (41)
Blood pressure increased (39)
Weight decreased (39)
Weight increased (34)
Inappropriate schedule of product administration (28)
Malaise (28)
Asthenia (25)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which BEVACIZUMAB-BVZR Alternatives Have Lower Neoplasm progression Risk?
BEVACIZUMAB-BVZR vs BEVACIZUMAB-MALY
BEVACIZUMAB-BVZR vs BEXAROTENE
BEVACIZUMAB-BVZR vs BEZAFIBRATE
BEVACIZUMAB-BVZR vs BEZLOTOXUMAB
BEVACIZUMAB-BVZR vs BGB-11417